FDA Adverse Event Injury Summary report: N

VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT

MDR report key: 9472906 · Received December 16, 2019

Report

Report Number
2210968-2019-90836
Event Type
Injury
Date Received
December 16, 2019
Report Date
November 26, 2019
Manufacturer
ETHICON INC.
Product Code
GAM
PMA / PMN Number
K022269
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. CITATION: TECH COLOPROCTOL (2008) 12:247¿249; DOI 10.1007/S10151-008-0427-5. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED VIA A JOURNAL ARTICLE"TITLE: TRANSANAL RESECTION OF RECTAL NEOPLASMS USING THE HARMONIC SCALPEL". AUTHOR(S): M. RABAU. CITATION: TECH COLOPROCTOL (2008) 12:247¿249; DOI 10.1007/S10151-008-0427-5. THIS STUDY AIMED TO PRESENT THE USE OF THE HARMONIC SCALPEL ALLOWING MORE PRECISE RESECTION OF RECTAL NEOPLASMS. OVER THE LAST YEAR (FROM THE TIME OF THE PUBLICATION), 14 PATIENTS WITH BENIGN ADENOMA (N=10), T1 ADENOCARCINOMA (N=3), AND T2 ADENOCARCINOMA (N=1) UNDERWENT TRANSANAL RESECTIONS USING HARMONIC SCALPEL. IN THE PROCEDURE, SUBMUCOSAL OR FULL-THICKNESS RESECTION ALONG THE MARKED MARGIN IS PERFORMED USING THE HARMONIC SCALPEL. THE RECTAL WOUND IS CLOSED WITH INTERRUPTED 000 VICRYL SUTURES. ALL THE PROCEDURES WENT SMOOTHLY, WITH A DRY SURGICAL FIELD AND NO NEED FOR CONTROL OF BLEEDING. ONE PATIENT WAS READMITTED WITH LATE POSTOPERATIVE BLEEDING WHICH OCCURRED 1 WEEK POSTOPERATIVELY AND REQUIRED SUTURE CONTROL. HARMONIC SCALPEL INSTEAD OF ELECTROCAUTERY ALLOWS A DRYER SURGICAL FIELD WHICH FACILITATES THE COMPLETE RESECTION OF THE NEOPLASM WITH GREATER ACCURACY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1269520 VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT SUTURE, ABSORBABLE, SYNTHETIC GAM ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention